| |
 |
|
Class Information
Number: 514/428
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons > Chalcogen bonded indirectly to the five-membered hetero ring by acyclic nonionic bonding
Description:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6864254 |
Inhibitor for 20-hete-yielding enzyme |
Mar. 8, 2005 |
| 6838477 |
Lactacystin analogs |
Jan. 4, 2005 |
| 6835727 |
Cathepsin cysteine protease inhibitors |
Dec. 28, 2004 |
| 6831097 |
2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
Dec. 14, 2004 |
| 6831106 |
Vitamin D analogues |
Dec. 14, 2004 |
| 6821998 |
Arylamines as inhibitors of chemokine binding to US28 |
Nov. 23, 2004 |
| 6821989 |
Method of treating certain cancers using an estrogen agonist/antagonist |
Nov. 23, 2004 |
| 6821965 |
Amidobenzamide derivatives which are useful as cytokine inhibitors |
Nov. 23, 2004 |
| 6812244 |
Naphthyl compounds, intermediates, compositions, and methods of use |
Nov. 2, 2004 |
| 6797504 |
Inhibitors of serine protease activity of matriptase or MTSP1 |
Sep. 28, 2004 |
| 6784175 |
Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments |
Aug. 31, 2004 |
| 6777424 |
Methods for treating osteoarthritis using an estrogen agonist / antagonist |
Aug. 17, 2004 |
| 6774136 |
Substituted 1 and 2 naphthol mannich bases |
Aug. 10, 2004 |
| 6767558 |
Inhibiting oxidative degradation of pharmaceutical formulations |
Jul. 27, 2004 |
| 6762187 |
Retroviral protease inhibitors |
Jul. 13, 2004 |
| 6756401 |
Compositions and methods for treating osteoporosis and lowering cholesterol |
Jun. 29, 2004 |
| 6750216 |
Kappa agonist compounds and pharmaceutical formulations thereof |
Jun. 15, 2004 |
| 6747027 |
Thiol sulfonamide metalloprotease inhibitors |
Jun. 8, 2004 |
| 6734185 |
Pyrrolo[3,4-d]pyrimidines as corticotropin releasing factor (CRF) antagonists |
May. 11, 2004 |
| 6720350 |
Therapeutic inhibitor of vascular smooth muscle cells |
Apr. 13, 2004 |
| 6716854 |
Treatments for restless legs syndrome |
Apr. 6, 2004 |
| 6713504 |
Antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate |
Mar. 30, 2004 |
| 6693137 |
Sulphonamide derivatives |
Feb. 17, 2004 |
| 6680319 |
Isoxazolecarboxamide derivatives |
Jan. 20, 2004 |
| 6680338 |
Hydroxamic and carboxylic acid derivatives |
Jan. 20, 2004 |
| 6680336 |
Cyclic AMP-specific phosphodiesterase inhibitors |
Jan. 20, 2004 |
| 6673787 |
Sulfonamide-containing indole compounds |
Jan. 6, 2004 |
| 6667310 |
Substituted guanidine derivatives |
Dec. 23, 2003 |
| 6653321 |
Naphthylsulfonic acids and related compounds as glucose uptake agonists |
Nov. 25, 2003 |
| 6641800 |
Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane |
Nov. 4, 2003 |
| 6642262 |
Riluzole and alpha-tocopherol combination |
Nov. 4, 2003 |
| 6641810 |
Methods of using geldanamycin and FK506 to treat peripheral nerve damage |
Nov. 4, 2003 |
| 6632834 |
Compositions and methods for treating conditions responsive to estrogen |
Oct. 14, 2003 |
| 6632841 |
Soluble compositions of triphenylethylene antiestrogens |
Oct. 14, 2003 |
| 6632840 |
Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them |
Oct. 14, 2003 |
| 6630476 |
Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists |
Oct. 7, 2003 |
| 6620843 |
Anticancer treatment using triptolide prodrugs |
Sep. 16, 2003 |
| 6620806 |
Methods and kits for improving vascular health |
Sep. 16, 2003 |
| 6613796 |
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
Sep. 2, 2003 |
| 6610705 |
Process for the preparation of diaryl naphthyl methanes |
Aug. 26, 2003 |
| 6608050 |
Lyophilizate of lipid complex of water insoluble porphyrins |
Aug. 19, 2003 |
| 6599920 |
Naphthalene compounds, intermediates, formulations, and methods |
Jul. 29, 2003 |
| 6599924 |
2-hetaryl-3,4-dihydro-2H-pyrrole derivatives |
Jul. 29, 2003 |
| 6593347 |
Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
Jul. 15, 2003 |
| 6576612 |
Antitumor therapy comprising distamycin derivatives |
Jun. 10, 2003 |
| 6576645 |
Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
Jun. 10, 2003 |
| 6569889 |
Amino ceramide-like compounds and therapeutic methods of use |
May. 27, 2003 |
| 6555570 |
Compounds with growth hormone releasing properties |
Apr. 29, 2003 |
| 6548533 |
Ureido substituted pyrrolidines |
Apr. 15, 2003 |
| 6545037 |
Benzenesulfonamide compounds |
Apr. 8, 2003 |
|
|
|
